Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (8): 799-805.doi: 10.3736/jcim20080806

• Original Clinical Research • Previous Articles     Next Articles

A study of the mechanism of Qingre Huatan therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and mucus hypersecretion

Weng Li1,2, Bing Mao1(), Gang Wang1, Lei Wang1, Jing Chang1, Ying Zhang1, Mei-hua Wan1, Jia Guo1   

  1. 1. Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China
    2. Department of Respiratory Medicine, the First People, s Hospital of Chengdu City, Chengdu, Sichuan Province 610000, China
  • Received:2008-02-20 Online:2008-08-20 Published:2008-08-15

Objective: To explore the effects of Tanreqing injection, a traditional Chinese herbal preparation for clearing heat and resolving phlegm, in treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) by improving airway inflammation and airway mucus hypersecretion.
Methods: A randomized controlled trial (RCT) was designed. Ninety AECOPD patients were randomly divided into Tanreqing group, ambroxol hydrochloride group and control group. The patients in the three groups were all treated with conventional therapy. Furthermore, intravenous drip infusion of 20 ml Tanreqing injection (once daily) and 15 mg ambroxol hydrochloride injection (twice daily) were administered respectively to the patients in the Tanreqing group and ambroxol hydrochloride group. They were all treated for 10 days. Symptom score of traditional Chinese medicine (TCM), plasma concentrations of interleukin-8 (IL-8), IL-10 and neutrophil elastase (NE) were detected before and after treatment.
Results: Cough, sputum amount, expectoration, dyspnea, fever, coated tongue and pulse tracings were improved obviously in Tanreqing group (P<0.05), and the effects of Tanreqing on improving cough, sputum amount and expectoration were better than the conventional therapy (P<0.05), while there was no significant difference between Tanreqing group and ambroxol hydrochloride group (P>0.05). Compared with ambroxol hydrochloride group and the control group, the coated tongue was improved obviously in Tanreqing group (P<0.05). After treatment, plasma concentrations of IL-8, IL-10 and NE were decreased in Tanreqing group and ambroxol hydrochloride group (P<0.05), and the levels of IL-8 and IL-10 in the control group were decreased (P<0.05). The change of IL-8 level before and after treatment in Tanreqing group was greater than that in ambroxol hydrochloride group and the control group. The changes of IL-10 and NE levels in ambroxol hydrochloride group were greater than those in Tanreqing group and the control group, while there was no significant difference in the changes of serum levels of IL-8, IL-10 and NE among the three groups (P>0.05). Total response rates in Tanreqing group and ambroxol hydrochloride group were higher than that in the control group (P<0.05), while there was no significant difference in total response rate between Tanreqing group and ambroxol hydrochloride group (P>0.05). There was no significant difference in total response rate among the three groups (P>0.05).
Conclusion: Tanreqing injection can improve TCM signs and symptoms in AECOPD patients, and the mechanism may be due to the decrease of serum levels of IL-8 and NE and improvement of IL-10 level.

Key words: chronic obstructive airway disease, clearing heat and resolving phlegm, randomized controlled trial, interleukin-8, interleukin-10, neutrophil elastase

CLC Number: 

  • R563.9

Table 1

Traditional Chinese medicine symptom score in three groups (x±s)"

Group n Symptom score Score difference
Pre-treatment Post-treatment
Control 26 12.4±4.7 6.1±5.6** 6.8±4.5
Ambroxol hydrochloride 24 13.8±4.8 3.3±2.3** 10.5±4.6△△
Tanreqing 28 15.0±4.2 3.7±2.9** 11.3±3.9△△

Table 2

Clinical effects in three groups[Cases (%)]"

Group n Cure Obvious effect Improvement Failure Total obvious effect Total response
Control 26 6 (23.08) 9 (34.61) 7 (26.92) 4 (15.39) 15 (57.69) 22 (84.61)
Ambroxol hydrochloride 24 6 (25.00) 14 (58.33) 2 (8.33) 2 (8.33) 20 (83.33) 22 (91.67)
Tanreqing 28 7 (25.00) 16 (57.14) 3 (10.72) 2 (7.14) 23 (82.14) 26 (92.86)

Table 3

Traditional Chinese medicine symptom in three groups (Cases)"

Group n Degree of pre-treatment Degree of post-treatment
0 2 4 6 0 2 4 6
Cough
Control 26 1 14 8 3 11 10 3 2*
Ambroxol hydrochloride 24 1 10 6 7 16 8 0 0**
Tanreqing 28 2 10 12 4 19 9 0 0**
Sputum amount
Control 26 1 11 12 2 10 11 2 3**
Ambroxol hydrochloride 24 2 10 4 8 15 9 0 0**
Tanreqing 28 0 11 13 4 15 13 0 0**
Expectoration
Control 26 2 10 7 7 10 11 3 2*
Ambroxol hydrochloride 24 1 7 6 10 15 9 0 0**
Tanreqing 28 0 6 11 11 16 12 0 0**
Dyspnea
Control 26 9 7 7 3 15 7 2 2**
Ambroxol hydrochloride 24 7 3 9 5 12 11 1 0**
Tanreqing 28 7 4 8 9 13 13 1 1**
Fever
Control 26 21 3 2 0 23 1 1 1
Ambroxol hydrochloride 24 22 1 1 0 23 1 0 0
Tanreqing 28 23 3 2 0 28 0 0 0

Table 4

Changes of coated tongue in three groups (Cases)"

Group n
Pre-treatment Post-treatment
Normal Abnormal Normal Abnormal
Control 26 5 21 11 15
Ambroxol hydrochloride 24 2 22 14 10**
Tanreqing 28 3 25 24 4**△△▲▲

Table 5

Changes of pulse tracings in three groups (Cases)"

Group n Pre-treatment Post-treatment
Normal Abnormal Normal Abnormal
Control 26 26 3 10 16*
Ambroxol hydrochloride 24 24 1 8 16*
Tanreqing 28 28 2 10 18*

Table 6

Levels of IL-8 and IL-10 in blood plasma before and after treatment in three groups"

Group n IL-8 IL-10
Pre-treatment Post-treatment Pre-treatment Post-treatment
Control (x±s, ng/L) 26 2.04±1.42 1.63±1.26** 3.94±3.10 1.92±1.37**
Ambroxol hydrochloride (x±s, ng/L) 24 2.15±1.75 1.41±0.56* 4.28±3.94 2.07±1.68**
Tanreqing (median, ng/L) 28 2.19 1.42* 3.15 1.32**

Table 7

Levels of NE in blood plasma before and after treatment in three groups (x±s, ng/L)"

Group n NE
Pre-treatment Post-treatment
Control 26 14.36±9.91 11.65±2.16
Ambroxol hydrochloride 24 16.99±13.47 13.32±9.60**
Tanreqing 28 15.43±10.02 12.25±9.03**
[1] Group of Chronic Obstructive Pulmonary Disease, the Branch of Respiratory Disease of China Medical Association. Diagnosis and treatment guidance of chronic obstructive pulmonary disease[J]. Zhonghua Nei Ke Za Zhi, 2007,46(3):254-261
中华医学会呼吸分会慢性阻塞性肺疾病组. 慢性阻塞性肺疾病诊治指南[J]. 中华内科杂志, 2007,46(3):254-261
[2] The Branch of Respiratory Disease of China Medical Association. Diagnosis and treatment guidance of chronic obstructive pulmonary disease[J]. Zhonghua Jie He He Hu Xi Za Zhi, 2002,25(8):453-460
中华医学会呼吸分会. 慢性阻塞性肺疾病诊治指南[J]. 中华结核和呼吸杂志, 2002,25(8):453-460
[3] Zhen XY. Guiding principle of clinical research on new drugs of Chinese medicine(trial implementation)[M]. Bejing: Chinese Medical Science and Technology Press,2002: 54-58
郑筱萸 . 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社,2002: 54-58
[4] Williams TJ, Jose PJ .Neutrophils in chronic obstructive pulmonary disease[J].Novartis Found Symp, 2001, 234: 136-141
doi: 10.1002/0470868678.ch9 pmid: 11199093
[5] Kim S, Nadel JA . Role of neutrophils in mucus hypersecretion in COPD and implications for therapy[J]. Treat Respir Med, 2004,3(3):147-159
doi: 10.2165/00151829-200403030-00003 pmid: 15219174
[6] Caramori G, Adcock I . Pharmacology of airway inflammation in asthma and COPD[J]. Pulm Pharmacol Ther, 2003,16(5):247-277
doi: 10.1016/S1094-5539(03)00070-1 pmid: 12877818
[7] Zhang LL, Li Z, Xu XY , et al. Main pharmacodynamics of Tanreqing capsule[J]. Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2004,10(3):37-40
张黎莉, 李展, 徐晓月 , 等. 痰热清胶囊的主要药效学研究[J]. 中国实验方剂学杂志, 2004,10(3):37-40
[8] Gao YM, Wang ZS . Initial evaluation of clinical medicine of Tanreqing injection[J]. Shou Du Yi Yao, 2004,11(12)
doi: 10.3969/j.issn.1005-8257.2004.12.021
高益民, 王忠山 . 对痰热清注射液临床药学初步评价[J]. 首都医药, 2004,11(12):44-46
doi: 10.3969/j.issn.1005-8257.2004.12.021
[9] Vernooy JH, Dentener MA, van Suylen RJ , et al.Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology[J]. Am J Respir Cell Mol Biol, 2002,26(1):152-159
doi: 10.1165/ajrcmb.26.1.4652
[10] Naiki Y, Michelsen KS, Zhang W , et al. Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling[J]. J Biol Chem, 2005,280(7):5491-5495
doi: 10.1074/jbc.C400503200
[11] Zhang Y, Li TQ, Wang G , et al. Randomized controlled trial of TanReqing injection in treatment of acute exacerbation of chronic obstructive pulmonary disease(syndrome of retention of phlegm-heat in the lung)[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2004,4(5):300-306
张颖, 李廷谦, 王刚 , 等. 痰热清注射液治疗慢性阻塞性肺疾病急性加重期(痰热阻肺证)的随机对照试验[J]. 中国循证医学杂志, 2004,4(5):300-306
[12] Zhu YQ . The effect of ambroxol against airway inflammation of patients with chronic obstructive pulmonary disease[J]. Hainan Yi Xue, 2006,17(12):6-7
doi: 10.3969/j.issn.1003-6350.2006.12.003
朱应群 . 氨溴索对慢性阻塞性肺疾病患者气道炎症的影响[J]. 海南医学, 2006,17(12):6-7
doi: 10.3969/j.issn.1003-6350.2006.12.003
[1] Chiung-Hui Huang, Mei-Ling Yeh, Fang-Pey Chen, Daphne Wu. Low-level laser acupuncture reduces postoperative pain and morphine consumption in older patients with total knee arthroplasty: A randomized placebo-controlled trial. Journal of Integrative Medicine, 2022, 20(4): 321-328.
[2] Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236.
[3] Ubiratan Cardinalli Adler, Maristela Schiabel Adler, Ana Elisa Madureira Padula, Livia Mitchiguian Hotta, Amarilysde Toledo Cesar, José Nelson Martins Diniz, Helen de Freitas Santos, Edson Zangiacomi Martinez. Homeopathy for COVID-19 in primary care: A randomized, double-blind, placebo-controlled trial (COVID-Simile study). Journal of Integrative Medicine, 2022, 20(3): 221-229.
[4] Xin Wang, Wen-juan Song, Yi Ruan, Bing-chu Li, Can Lü, Nian Huang, Fan-fu Fang, Wei Gu. Core muscle functional strength training for reducing the risk of low-back pain in military recruits: An open-label randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 145-152.
[5] Meng-zhu Zhao, Chen Zhao, Shuang-shuang Tu, Xu-xu Wei, Hong-cai Shang. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials. Journal of Integrative Medicine, 2021, 19(4): 317-326.
[6] Si-chun Gu, Jie Zhou, Qing Ye, Can-xing Yuan. Pingchan granule for depressive symptoms in Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2021, 19(2): 120-128.
[7] Jie Wu, Shu-wei Duan, Hong-tao Yang, Yue-yi Deng, Wei Li, Ya-ni He, Zhao-hui Ni, Yong-li Zhan, Shan Lin, Zhi-yong Guo, Jun Zhu, Jing-ai Fang, Xu-sheng Liu, Li-hua Wang, Rong Wang, Nian-song Wang, Xiao-hong Cheng, Li-qun He, Ping Luo, Shi-ren Sun s, Ji-feng Sun, Ai-ping Yin, Geng-ru Jiang, Hong-yu Chen, Wen-hu Liu, Hong-li Lin, Meng Liang, Lu Ma, Ming Chen, Li-qun Song, Jian Chen, Qing Zhu, Chang-ying Xing, Yun Li, Ji-ning Gao, Rong-shan Li, Ying Li, Hao Zhang, Ying Lu, Qiao-ling Zhou, Jun-zhou Fu, Qiang He, Guang-yan Cai, Xiang-mei Chen. Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial. Journal of Integrative Medicine, 2021, 19(2): 111-119.
[8] Xian Wang, Xuan Yin, Xiu-tian Guo, Yan Wang, Wen-qi Jin, Ai-jun Mao, Lixing Lao, Zhang-jin Zhang, Jie Zhang, Shi-fen Xu. Effects of the pestle needle therapy, a type of acupoint stimulation, on post-hemorrhoidectomy pain: A randomized controlled trial. Journal of Integrative Medicine, 2020, 18(6): 492-498.
[9] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[10] Gerli E.G. Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, Fabricia Petronilho, Lucinéia Gainski Danielski, Mariana Pereira de Souza Goldim, Afonso Shiguemi Inoue Salgado, Franciane Bobinski, Daniel Fernandes Martins, Eliane R. Winkelmann. Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial. Journal of Integrative Medicine, 2020, 18(1): 27-.
[11] Xin-yu Yue, Zhuo-qi Feng, Xi-yi Yu, Jia-min Hu, Xiao-Jing He, Shi Shu. Fire-needle acupuncture for upper limb spastic paralysis after stroke: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 167-172.
[12] Pádraic J.Dunne, Julie Lynch, Lucia Prihodova, Caoimhe O'Leary, Atiyeh Ghoreyshi, Sharee A. Basdeo, Donal J.Cox, Rachel Breen, Ali Sheikhi, Áine Carroll, Cathal Walsh, Geraldine McMahon, Barry White. Burnout in the emergency department: Randomized controlled trial of an attention-based training program. Journal of Integrative Medicine, 2019, 17(3): 173-180.
[13] Ya-ru Huangfu, Wei Peng, Bao-jun Guo, Zhi-fu Shen, Li Li, Shi-wei, Liu, Hui Zheng, You-ping Hu. Effects of acupuncture in treating insomnia due to spleen-stomach disharmony syndrome and its influence on intestinal microbiome: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 161-167.
[14] J.M. Oliver-Baxter, H.S. Whitford, D.A. Turnbull, M.J. Bond. Effects of vitamin supplementation on inflammatory markers and psychological wellbeing among distressed women: A randomized controlled trial. Journal of Integrative Medicine, 2018, 16(5): 322-328.
[15] Parunkul Tungsukruthai, Preecha Nootim, Wiwan Worakunphanich, Nareerat Tabtong. Efficacy and safety of herbal steam bath in allergic rhinitis: A randomized controlled trial. Journal of Integrative Medicine, 2018, 16(1): 39-44.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228